- Investing Ideas
- Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
160
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
160 companies
Chi Sheng Pharma & Biotech
Market Cap: NT$1.8b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$29.95
7D
-1.3%
1Y
-1.1%
Immuno-Biological Laboratories
Market Cap: JP¥8.8b
Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.
4570
JP¥942.00
7D
-5.8%
1Y
90.7%
CCME Global
Market Cap: ₹5.1b
Does not have significant operations.
514336
₹113.55
7D
-1.2%
1Y
362.5%
Synbio Tech
Market Cap: NT$1.7b
Manufactures and sells human healthcare products and probiotics for animals.
1295
NT$48.50
7D
-1.8%
1Y
-59.4%
Haleos Labs
Market Cap: ₹4.7b
Engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.
HALEOSLABS
₹1,571.10
7D
-1.6%
1Y
26.2%
BIO-FD&CLtd
Market Cap: ₩72.8b
Develops active ingredients for anti-aging cosmetics in South Korea.
A251120
₩8,370.00
7D
-2.1%
1Y
-57.7%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$345.5m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.31
7D
6.9%
1Y
0%
WDB coco
Market Cap: JP¥6.2b
Provides contract and human resource services to pharmaceutical companies in Japan.
7079
JP¥2,580.00
7D
-1.1%
1Y
-11.0%
Prince Pharmaceutical
Market Cap: NT$1.1b
Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.
6935
NT$30.25
7D
-0.2%
1Y
15.5%
P&K Skin Research Center
Market Cap: ₩50.5b
Engages in the evaluation and research of dermatological products in South Korea.
A347740
₩1,747.00
7D
-1.1%
1Y
-43.4%
Bioqual
Market Cap: US$29.1m
Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.
BIOQ
US$32.50
7D
0%
1Y
-24.8%
Vitura Health
Market Cap: AU$20.5m
Engages in the sale and distribution of medicinal cannabis products in Australia.
VIT
AU$0.031
7D
10.7%
1Y
-54.4%
Par Drugs and Chemicals
Market Cap: ₹1.3b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.
PAR
₹104.93
7D
17.1%
1Y
-1.2%
Pharma-Bio Serv
Market Cap: US$13.3m
Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.50
7D
-11.5%
1Y
-16.7%
Phong Phu Pharmaceutical
Market Cap: ₫158.4b
Engages in the production, sale, and distribution of medicines primarily in Vietnam.
PPP
₫18,000.00
7D
0%
1Y
-16.3%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%